Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response - Concepedia

Concepedia

Publication | Closed Access

Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response

33

Citations

41

References

2008

Year

Mahmoud M. Iravani, Mona Sadeghian, Clement Leung, Banu Cahide Tel, Sarah Rose, Anthony H.V. Schapira, Peter Jenner

Experimental Neurology

InflammationImmunologyPharmacologyInflammatory ResponsePramipexole ProtectsClinical PharmacologyExperimental PharmacologyPharmacotherapyMedicineContinuous Subcutaneous Infusion

References

	Year	Citations

Page 1